{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:58:54Z","timestamp":1793973534522,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"State Key Project on Infectious Diseases of China","award":["2012ZX10002016"],"award-info":[{"award-number":["2012ZX10002016"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81372483"],"award-info":[{"award-number":["81372483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"crossref","award":["16ZR1400100"],"award-info":[{"award-number":["16ZR1400100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Guidance Foundation of Shanghai","award":["16411966200"],"award-info":[{"award-number":["16411966200"]}]},{"name":"Foundation of Shanghai Health and Family Planning Commision","award":["201540381"],"award-info":[{"award-number":["201540381"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.hpb.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T19:38:13Z","timestamp":1533325093000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Jianwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2018.07.005_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2018.07.005_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2018.07.005_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","article-title":"Hepatocellular carcinoma in the Asia pacific region","volume":"24","author":"Yuen","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2018.07.005_bib5","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56 Suppl.\u00a01","author":"de Lope","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hpb.2018.07.005_bib7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2018.07.005_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"Management of hepatocellular carcinoma","volume":"56","author":"EASL-EORTC clinical practice guidelines","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2018.07.005_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2018.07.005_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2018.07.005_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s11605-009-0868-9","article-title":"Transplantation versus resection for hepatocellular carcinoma in the mild cirrhotic: framing the debate","volume":"13","author":"Choti","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2018.07.005_bib14","first-page":"107","article-title":"A\u00a0review of current status of living donor liver transplantation","volume":"5","author":"Park","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hpb.2018.07.005_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncpgasthep1300","article-title":"East meets the West\u2013portal pressure predicts outcome of surgical resection for hepatocellular carcinoma","volume":"6","author":"Forner","year":"2009","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.12199","article-title":"Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients","volume":"33","author":"Giannini","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.hpb.2018.07.005_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/bjs.8861","article-title":"Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma","volume":"99","author":"Hidaka","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.07.005_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/bjs.8753","article-title":"Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis","volume":"99","author":"Boleslawski","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2018.07.005_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2011.06.027","article-title":"Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors","volume":"56","author":"Llop","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib20","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1245\/s10434-008-9880-7","article-title":"Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis","volume":"15","author":"Kawano","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.07.005_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1478-3231.2010.02436.x","article-title":"Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma","volume":"31","author":"Choi","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.hpb.2018.07.005_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00268-005-0524-9","article-title":"Portal hypertension: contraindication to liver surgery?","volume":"30","author":"Capussotti","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2018.07.005_bib23","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.3748\/wjg.v17.i46.5083","article-title":"Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?","volume":"17","author":"Ruzzenente","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2018.07.005_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1477-2574.2012.00594.x","article-title":"Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?","volume":"15","author":"Santambrogio","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.07.005_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","article-title":"Is portal hypertension a contraindication to hepatic resection?","volume":"250","author":"Cucchetti","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.07.005_bib26","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2018.07.005_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12885-015-1280-3","article-title":"The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis","volume":"15","author":"He","year":"2015","journal-title":"BMC Canc"},{"key":"10.1016\/j.hpb.2018.07.005_bib28","doi-asserted-by":"crossref","first-page":"e108755","DOI":"10.1371\/journal.pone.0108755","article-title":"Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2018.07.005_bib29","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1097\/MD.0000000000000495","article-title":"Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation","volume":"94","author":"Xiao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hpb.2018.07.005_bib30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2018.07.005_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2018.07.005_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hpb.2018.07.005_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2006-951603","article-title":"Measurement of portal pressure and its role in the management of chronic liver disease","volume":"26","author":"Bosch","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hpb.2018.07.005_bib34","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","article-title":"Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis","volume":"7","author":"Qamar","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hpb.2018.07.005_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hpb.2018.07.005_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.hpb.2018.07.005_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2018.07.005_bib40","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3748\/wjg.v19.i8.1193","article-title":"Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension","volume":"19","author":"Hernandez-Gea","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2018.07.005_bib41","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47 Suppl","author":"Mittal","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.hpb.2018.07.005_bib42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12885-015-1318-6","article-title":"Association between epidermal growth factor gene\u00a0+61A\/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies","volume":"15","author":"Jiang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2018.07.005_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1148\/radiol.2015150177","article-title":"The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm: a meta-analysis","volume":"278","author":"Kierans","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.hpb.2018.07.005_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12957-015-0516-7","article-title":"Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"13","author":"Yang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2018.07.005_bib45","doi-asserted-by":"crossref","first-page":"vii41","DOI":"10.1093\/annonc\/mds225","article-title":"Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23 Suppl.\u00a07","author":"Verslype","year":"2012","journal-title":"Ann Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1832690X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1832690X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:17:49Z","timestamp":1761265069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X1832690X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1365182X1832690X"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2018.07.005","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}